CTRI/2018/11/016272已完成未知
Molecular Diagnosis and Risk Stratification of Sepsis in India - MARS-India
Prof Dr Chiranjay Mukhopadhyay0 个研究点目标入组 1,252 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,252
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients aged 18 years and over in the intensive care units of Kasturba Hospital, Manipal
排除标准
- •Age less than 18 years
- •Pregnant or breast-feeding women
- •Patients with a withdrawal of care decision at time of inclusion
- •Patients whose anticipated duration of hospitalisation in ICU is estimated less than 48 hours
- •Extra-corporeal circulation in the month preeceding inclusion in the case of cardiac surgery
- •Patient with restricted liberty or under legal protection
- •Expected lifespan less than 3 months due to pre-existing co-morbidities
- •Blood transfusion greater than 4 units in past week
- •Second admission to ICU or previous enrolment in study (within same hospital admission)
- •Transfer from other hospital IC
研究者
相似试验
招募中
不适用
Towards novel BIOmarkers to diagnose SEPsis on the emergency roomBlood poisoning10004018SepsisNL-OMON51785Amsterdam UMC3,120
已完成
不适用
Clinical evaluation of molecular detection for sentinel lymph node examination in breast cancer patientsPrimary breast cancerJPRN-UMIN000005321Japanese Study Group of the OSNA assay450
招募中
不适用
Molecular biological study to elucidate pathogenicity of epicardial adipose tissueJPRN-UMIN000043455Hiroshima University50
招募中
Unknown
Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.Pancreatic carcinoma in situ Small pancreatic ductal adenocarcinomaJPRN-UMIN000048934Oita University Faculty of Medicine50
尚未招募
不适用
Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MSung cancerITMCTR1900002555The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine